We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Glycotope Receives Innovation Award Berlin Brandenburg 2010

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Glycotope Receives Innovation Award Berlin Brandenburg 2010"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
Glycotope GmbH, has won the innovation award 2010 jointly presented by the German states of Berlin and Brandenburg in recognition of the company’s GlycoExpress™ technology platform.

GlycoExpress™ combines a very efficient improvement of the activities and side effects of a broad range of protein biopharmaceuticals with the suitability for a much broader patient population and a very high productivity, the company claims. Currently four therapeutic proteins (3 antibodies) have been produced under GMP two of which are currently tested in clinical trials.

“We are highly delighted”, says Dr. Steffen Goletz, CEO, CSO and Founder of Glycotope GmbH. “After receiving the STEP award 2010, winning another prestigious prize within short time is an important recognition of our scientific and corporate advances we have accomplished over the last years”.

With close to 70 employees just at the Biotech-campus in Berlin-Buch, Glycotope has developed into an outstanding representative of the Biotech region Berlin-Brandenburg.